ICON Gestion
Gestion contrôle des critères 4/4
Le PDG ICON est Steve Cutler, nommé en Mar2017, a un mandat de 7.67 ans. La rémunération annuelle totale est $ 7.24M, composée du salaire de 16.4% et des bonus 83.6%, y compris les actions et options de la société. détient directement 0.045% des actions de la société, d'une valeur de $ 7.90M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 8.3 ans et 7.6 ans.
Informations clés
Steve Cutler
Directeur général
US$7.2m
Rémunération totale
| Pourcentage du salaire du PDG | 16.4% |
| Durée du mandat du directeur général | 7.7yrs |
| Propriété du PDG | 0.04% |
| Durée moyenne d'occupation des postes de direction | 8.3yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 7.6yrs |
Mises à jour récentes de la gestion
Recent updates
With A 25% Price Drop For ICON Public Limited Company (NASDAQ:ICLR) You'll Still Get What You Pay For
Nov 02
Here's Why ICON (NASDAQ:ICLR) Has Caught The Eye Of Investors
Sep 25Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?
Sep 09We Think ICON (NASDAQ:ICLR) Can Stay On Top Of Its Debt
Aug 25An Intrinsic Calculation For ICON Public Limited Company (NASDAQ:ICLR) Suggests It's 28% Undervalued
Aug 10ICON: Deleveraging Complete, Now See 18% CAGR In Valuation To FY'26E (Rating Upgrade)
Jul 13Earnings Tell The Story For ICON Public Limited Company (NASDAQ:ICLR)
Jun 14Here's Why We Think ICON (NASDAQ:ICLR) Is Well Worth Watching
May 30ICON (NASDAQ:ICLR) Has A Pretty Healthy Balance Sheet
May 14ICON Public Limited Company Just Recorded A 8.9% EPS Beat: Here's What Analysts Are Forecasting Next
Apr 28What Does ICON Public Limited Company's (NASDAQ:ICLR) Share Price Indicate?
Apr 21ICON Public Limited Company's (NASDAQ:ICLR) Intrinsic Value Is Potentially 33% Above Its Share Price
Apr 05ICON Public Limited Company (NASDAQ:ICLR) Looks Just Right With A 27% Price Jump
Mar 05With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case
Feb 07ICON: Will The Huge Acquisition Of PRA Continue To Create Synergies?
Feb 01These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well
Jan 23Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?
Jan 08What You Can Learn From ICON Public Limited Company's (NASDAQ:ICLR) P/E
Dec 24A Look At The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)
Dec 09With EPS Growth And More, ICON (NASDAQ:ICLR) Makes An Interesting Case
Nov 08Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching
Oct 09Is ICON (NASDAQ:ICLR) Using Too Much Debt?
Sep 23Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)
Sep 05Does ICON (NASDAQ:ICLR) Deserve A Spot On Your Watchlist?
Aug 03Is It Too Late To Consider Buying ICON Public Limited Company (NASDAQ:ICLR)?
Jun 30Is ICON (NASDAQ:ICLR) Using Too Much Debt?
Jun 12Calculating The Fair Value Of ICON Public Limited Company (NASDAQ:ICLR)
May 23Should You Think About Buying ICON Public Limited Company (NASDAQ:ICLR) Now?
Mar 29Is ICON (NASDAQ:ICLR) Using Too Much Debt?
Mar 11Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 28%?
Feb 21Why ICON Public Limited Company (NASDAQ:ICLR) Could Be Worth Watching
Dec 28These 4 Measures Indicate That ICON (NASDAQ:ICLR) Is Using Debt Reasonably Well
Dec 10Is ICON Public Limited Company (NASDAQ:ICLR) Trading At A 26% Discount?
Nov 22Icon selected by BARDA to conduct anthrax vaccine clinical trial
Oct 06Is ICON Public Limited Company (NASDAQ:ICLR) Potentially Undervalued?
Sep 15ICON (NASDAQ:ICLR) Seems To Use Debt Quite Sensibly
Aug 26Baron Funds - ICON Plc: Positioned For An Extended Period Of Revenue And Earnings Growth
Aug 11Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 41%?
Aug 01Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$748m |
| Jun 30 2024 | n/a | n/a | US$714m |
| Mar 31 2024 | n/a | n/a | US$683m |
| Dec 31 2023 | US$7m | US$1m | US$612m |
| Sep 30 2023 | n/a | n/a | US$513m |
| Jun 30 2023 | n/a | n/a | US$510m |
| Mar 31 2023 | n/a | n/a | US$510m |
| Dec 31 2022 | US$10m | US$1m | US$505m |
| Sep 30 2022 | n/a | n/a | US$464m |
| Jun 30 2022 | n/a | n/a | US$210m |
| Mar 31 2022 | n/a | n/a | US$168m |
| Dec 31 2021 | US$10m | US$1m | US$153m |
| Sep 30 2021 | n/a | n/a | US$178m |
| Jun 30 2021 | n/a | n/a | US$364m |
| Mar 31 2021 | n/a | n/a | US$338m |
| Dec 31 2020 | US$8m | US$1m | US$328m |
| Sep 30 2020 | n/a | n/a | US$322m |
| Jun 30 2020 | n/a | n/a | US$324m |
| Mar 31 2020 | n/a | n/a | US$368m |
| Dec 31 2019 | US$8m | US$1m | US$369m |
| Sep 30 2019 | n/a | n/a | US$362m |
| Jun 30 2019 | n/a | n/a | US$353m |
| Mar 31 2019 | n/a | n/a | US$333m |
| Dec 31 2018 | US$8m | US$1m | US$323m |
| Sep 30 2018 | n/a | n/a | US$306m |
| Jun 30 2018 | n/a | n/a | US$295m |
| Mar 31 2018 | n/a | n/a | US$288m |
| Dec 31 2017 | US$7m | US$1m | US$281m |
Rémunération vs marché: La rémunération totale de Steve ($USD 7.24M ) est inférieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 12.64M ).
Rémunération et revenus: La rémunération de Steve a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Steve Cutler (64 yo)
7.7yrs
Titularisation
US$7,244,000
Compensation
Dr. Steven A. Cutler, also known as Steve, Ph D., MBA, serves as Chairman of Association of Clinical Research Organizations since January 01, 2021. He has been the Chief Executive Officer of ICON Public Li...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Director | 7.7yrs | US$7.24m | 0.045% $ 7.9m | |
| Founder & Independent Non-Executive Director | no data | US$290.00k | 0.54% $ 95.7m | |
| Chief Financial Officer | less than a year | pas de données | pas de données | |
| Senior Vice President of Corporate & Commercial Finance | no data | pas de données | pas de données | |
| Chief Information Officer | no data | pas de données | pas de données | |
| Chief Administrative Officer | 15yrs | pas de données | 0.0097% $ 1.7m | |
| Director of Corporate Communications | no data | pas de données | pas de données | |
| Vice President of Marketing | no data | pas de données | pas de données | |
| Chief Human Resources Officer | 8.3yrs | pas de données | pas de données | |
| President of Corporate Investments & Partnerships | 2yrs | pas de données | pas de données | |
| Senior Vice President of Global Clinical Pharmacology | 15.6yrs | pas de données | pas de données | |
| Senior Vice President of Drug Development Services - CNS | 17.8yrs | pas de données | pas de données |
8.3yrs
Durée moyenne de l'emploi
53.5yo
Âge moyen
Gestion expérimentée: L'équipe dirigeante de ICLR est chevronnée et expérimentée (8.3 années d'ancienneté moyenne).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| CEO & Director | 9yrs | US$7.24m | 0.045% $ 7.9m | |
| Founder & Independent Non-Executive Director | 14.8yrs | US$290.00k | 0.54% $ 95.7m | |
| Independent Director | 3.3yrs | US$303.00k | 0.0054% $ 943.6k | |
| Independent Non-Executive Director | 7.1yrs | US$323.00k | 0.0026% $ 451.6k | |
| Independent Non-Executive Chairman of the Board | 13.1yrs | US$656.00k | 0.023% $ 4.1m | |
| Lead Independent Director | 8.1yrs | US$359.00k | 0.0026% $ 451.6k | |
| Non-Executive Director | less than a year | pas de données | pas de données | |
| Independent Non-Executive Director | 5.3yrs | US$315.00k | 0.0023% $ 411.2k |
7.6yrs
Durée moyenne de l'emploi
64.5yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de ICLR sont considérés comme expérimentés (ancienneté moyenne 7.6 ans).